Cargando…

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients

Extensive intratumoral heterogeneity (ITH) is believed to contribute to therapeutic failure and tumor recurrence, as treatment-resistant cell clones can survive and expand. However, little is known about ITH in triple-negative breast cancer (TNBC) because of the limited number of single-cell sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qi, Kaur, Jaspreet, Wylie, Dennis, Mittal, Karuna, Li, Hongxiao, Kolachina, Rishab, Aleskandarany, Mohammed, Toss, Michael S., Green, Andrew R., Yang, Jianchen, Yankeelov, Thomas E., Bhattarai, Shristi, Janssen, Emiel A. M., Kong, Jun, Rakha, Emad A., Kowalski, Jeanne, Aneja, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655720/ https://www.ncbi.nlm.nih.gov/pubmed/36362107 http://dx.doi.org/10.3390/ijms232113322

Ejemplares similares

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
por: Mittal, Karuna, et al.
Publicado: (2022)

Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers
por: Kaur, Jaspreet, et al.
Publicado: (2022)

Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
por: Ogden, Angela, et al.
Publicado: (2020)

Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers
por: Kaur, Jaspreet, et al.
Publicado: (2023)

Machine learning-based prediction of breast cancer growth rate in vivo
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
por: Fisher, Timothy B., et al.
Publicado: (2023)

Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors
por: Nwagu, Gift C., et al.
Publicado: (2021)

Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives
por: Wright, Nikita, et al.
Publicado: (2018)

Panoptic View of Prognostic Models for Personalized Breast Cancer Management
por: Saini, Geetanjali, et al.
Publicado: (2019)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells
por: Mittal, Karuna, et al.
Publicado: (2017)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

Quadruple-negative breast cancer: novel implications for a new disease
por: Bhattarai, Shristi, et al.
Publicado: (2020)

Quadruple-Negative Breast Cancer: An Uneven Playing Field
por: Saini, Geetanjali, et al.
Publicado: (2020)

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer
por: Garlapati, Chakravarthy, et al.
Publicado: (2023)

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis
por: Klimov, Sergey, et al.
Publicado: (2021)

A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
por: Klimov, Sergey, et al.
Publicado: (2019)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer
por: Kariri, Yousif A., et al.
Publicado: (2019)

XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib
por: Ali, Reem, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
por: Seth, Gaurav, et al.
Publicado: (2020)

The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development
por: Aljohani, Abrar I., et al.
Publicado: (2022)

An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines
por: Yang, Jianchen, et al.
Publicado: (2021)

Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
por: Ogden, Angela, et al.
Publicado: (2017)

QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation
por: Bhattarai, Shristi, et al.
Publicado: (2021)

Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods
por: Lashen, Ayat, et al.
Publicado: (2022)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Deep learning based registration of serial whole-slide histopathology images in different stains
por: Roy, Mousumi, et al.
Publicado: (2023)

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015)

The characteristics and clinical significance of atypical mitosis in breast cancer
por: Lashen, Ayat, et al.
Publicado: (2022)

Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
por: Joshi, Shriya, et al.
Publicado: (2022)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in Georgia
por: Awan, Sofia, et al.
Publicado: (2023)

Refining the definition of HER2‐low class in invasive breast cancer
por: Atallah, Nehal M, et al.
Publicado: (2022)

Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
por: Sonbul, Sultan N, et al.
Publicado: (2017)

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
por: Joseph, Chitra, et al.
Publicado: (2019)

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
por: Johnston, Simon J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gj03k1mfcrb6f1so8nm8qagcin